endoglin peptides (Tufts Medical Center)

N/A

Report date: 2025/03/20 15:10:24

Base Information

Drug Nameendoglin peptides (Tufts Medical Center)
Drug Alias NameCD-105 peptides (Tufts Medical Center)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic DiseasesCardiovascular DiseasesPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTufts Medical Center Inc
China Registration ClassN/A

Develop Information

Active CompaniesTufts Medical Center Inc
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesCardiovascular DiseasesPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A